FDA Opens Formal Safety Reassessment of BHT: What It Means

WASHINGTON, Sept. 8, 2026 -- The U.S. Food and Drug Administration has formally opened a safety reassessment of butylated hydroxytoluene (BHT), the synthetic antioxidant that keeps cereals, chips and cooking oils from going rancid. BHT stays legal while the review runs; nothing is being recalled. Here is what the agency actually did, what it did not do, and what it means at the shelf.

Key takeaways

• On May 12, 2026, the FDA finalized its post-market food chemical safety assessment program and named BHT and azodicarbonamide (ADA) as its first two reassessments.
• The FDA published a Request for Information on BHT's current uses and safety data on May 13, 2026; the comment period, originally set to close July 13, 2026, was reopened on July 29 and closed on August 31, 2026. A reassessment is a review, not a ban or recall.
• BHT remains permitted in the U.S. as a direct food antioxidant, typically capped at 0.02% of a food's fat or oil content, and in food packaging.
• In the EU, BHT (E 321) is authorized with an Acceptable Daily Intake of 0.25 mg per kilogram of body weight per day set by EFSA.
• BHT must be declared by name on U.S. ingredient lists, so shoppers who want to limit it can spot it easily.

What happened

On May 12, 2026, the FDA announced that it had finalized the framework for its food chemical safety post-market assessment program and, in the same announcement, launched reassessments of two long-authorized additives: butylated hydroxytoluene (BHT) and azodicarbonamide (ADA). The program is the agency's answer to a long-standing criticism that chemicals approved decades ago were rarely re-examined against newer science and modern consumption patterns.

The next day the agency published a Request for Information on BHT in the Federal Register, asking industry, researchers and the public for current use levels, exposure estimates and toxicology data for BHT both as a direct food ingredient and as a food contact substance. The comment period originally closed on July 13, 2026; the FDA reopened it on July 29, 2026, and it closed for good on August 31, 2026. The FDA has not announced a decision or a timeline for one.

BHT also appears on the agency's public list of select chemicals in the food supply under FDA review, alongside its chemical cousin BHA, which is also under review. Under current regulations (21 CFR 172.115 and 21 CFR 182.3173), BHT remains authorized for use as an antioxidant in foods and in dry food packaging while the review proceeds.

What changed

While no immediate nationwide ban has been enacted, the broader regulatory environment for synthetic preservatives has shifted toward structured reassessment. In Europe, the European Food Safety Authority completed comprehensive toxicological reviews establishing an Acceptable Daily Intake (ADI) of 0.25 mg per kilogram of body weight per day for the additive coded as E 321.

In addition, cosmetic and topical applications of BHT have faced refined concentration limits. The European Commission Scientific Committee on Consumer Safety (SCCS) concluded that BHT is safe as an antioxidant in cosmetic products up to specific maximum concentrations, such as 0.8% in general formulations. In contrast, U.S. rules continue to permit BHT at established historical thresholds, typically 0.02% (200 ppm) based on the total fat or oil content of the finished food item.

These differences reflect divergent approaches to additive management, similar to discussions outlined in EU warning-label additives still allowed in the us and broader administrative proposals detailed in FDA proposes ending self-affirmed GRAS: what changes for you.

Manufacturers operating across international markets increasingly navigate these technical differences by modifying product formulations. In regions where additive thresholds or consumer preferences limit synthetic antioxidants, companies frequently swap out E 321 for alternative shelf-life extenders.

Who is affected

This regulatory focus directly impacts manufacturers of shelf-stable packaged foods and consumers who routinely purchase them. BHT is widely utilized across specific product categories where lipid oxidation causes spoilage, including:

• Ready-to-eat breakfast cereals and granola bars
• Potato chips, extruded corn snacks, and shelf-stable crackers
• Dehydrated potato flakes and dry baking mixes
• Cooking oils, shortening, and animal fats
• Food contact materials, such as the wax liners inside cereal boxes

From a demographic perspective, individuals consuming high amounts of shelf-stable packaged goods have a higher relative cumulative intake compared to those consuming primarily fresh or minimally processed foods. However, general population exposure estimates in most standard diets currently remain within established international ADI ranges.

Food processors and commercial bakeries must carefully monitor additive concentrations to ensure compliance with formulation limits. For brands distributing globally, maintaining separate supply chains for domestic formulas and export products meeting European standards requires continuous quality control and regulatory tracking.

What it means for shoppers

For everyday grocery shoppers, ongoing chemical reassessments do not mean your pantry products are unsafe or subject to mandatory market withdrawals. A scientific review is an analytical process to verify safe consumption thresholds, not an active food safety alert.

If you want to identify or moderate your household intake of BHT, consider the following label-reading practices:

• Check the ingredient list: regulators require BHT to be explicitly listed by its common name, often alongside a functional descriptor such as "BHT added to preserve freshness" or "BHT added to packaging to maintain crispness."
• Look at packaging liners: When BHT is incorporated into the plastic or wax packaging rather than directly mixed into the food, brands frequently state "BHT added to packaging material" at the end of the ingredient statement.
• Identify alternatives: Many food brands have voluntarily switched to natural antioxidant alternatives, such as mixed tocopherols (vitamin E), rosemary extract, or ascorbic acid (vitamin C).

Checking ingredient panels helps you make informed choices without needing to navigate alarmist claims. To quickly check your groceries, shoppers can scan food labels with Aurascan to identify additives like BHT and see clear ingredient explanations.

The background

Synthesized commercially by reacting para-cresol with isobutylene under heat and catalytic pressure, butylated hydroxytoluene is a synthetic phenolic antioxidant. Its chemical structure allows it to donate hydrogen atoms to free radicals, breaking the chain reaction of auto-oxidation that causes fats and oils to turn rancid, develop off-flavors, and degrade in nutritional quality.

BHT was first introduced to industrial and food manufacturing in the mid-twentieth century. The Joint FAO/WHO Expert Committee on Food Additives (JECFA) and the International Agency for Research on Cancer (IARC) have evaluated BHT across several decades. IARC classifies BHT under Group 3, meaning it is not classifiable as to its carcinogenicity to humans due to inadequate clinical evidence in human studies.

Toxicological studies indicate that when ingested, BHT is metabolized by the liver into benzoic acid derivatives and glucuronide conjugates before urinary excretion. EFSA's ADI rests on a no-observed-adverse-effect level of 25 mg per kilogram of body weight from two-generation rat studies, in which higher doses reduced litter size and produced other reproductive effects alongside liver weight increases and altered thyroid hormone metabolism; applying a 100-fold uncertainty factor gives the 0.25 mg/kg figure.

Evidence limitations exist: current scientific data cannot establish individual physiological sensitivities, long-term multi-additive cumulative interaction effects in humans, or exact outcomes across unstudied populations.

Understanding these historical evaluations contextualizes why BHT remains widely used while being subjected to ongoing toxicological reviews as analytical sensitivity improves.

What to watch next

• FDA findings on BHT: The agency has not set a date. The first public signal will be a safety assessment summary or a proposed regulatory action published on the post-market program page; both would be followed by another comment period.
• The parallel ADA and BHA reviews: Decisions on azodicarbonamide and BHA, which share the same review track, will show how the new program handles legacy additives in practice.
• State laws: Several states have introduced bills modeled on California's additive restrictions that name BHT or BHA; a state ban would bite before any federal decision.
• Reformulation: Brands already swapping BHT for mixed tocopherols or rosemary extract for clean-label reasons will keep doing so regardless of the federal outcome; check packaging for the "BHT added to preserve freshness" line to see who still uses it.

Evidence limitations remain: current data cannot establish individual sensitivities or long-term effects of combined additive exposure, which is precisely the gap the FDA review is meant to examine.